Literature DB >> 20526846

Evaluation of the V404I and V509M amino acid substitutions of ERG11 gene in Candida albicans isolates by pyrosequencing.

T-H Kim1, M-K Lee.   

Abstract

The molecular mechanisms underlying fluconazole resistance in C. albicans involve mutations and the overexpression of the ERG11 gene and membrane transport proteins. We examined the relationship between the reduced fluconazole susceptibility of C. albicans and mutations of V404I and V509M in the ERG11 gene in 182 C. albicans clinical isolates using the Pyrosequencing method. DNAs from these clinical isolates with different levels of in-vitro fluconazole susceptibility--one resistant, five susceptible dose-dependent (SDD), four trailer, and 172 susceptible--were analyzed. None of the fluconazole-susceptible, SDD, trailer or resistant isolates had mutations of V404I or V509M. Our results showed that no correlation can be found between the V404I or V509M mutation and fluconazole susceptibility in C. albicans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20526846     DOI: 10.1007/s12223-010-0045-2

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  20 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

Review 2.  Pyrosequencing for microbial typing.

Authors:  Mostafa Ronaghi; Elahe Elahi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-12-25       Impact factor: 3.205

3.  Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450.

Authors:  K Asai; N Tsuchimori; K Okonogi; J R Perfect; O Gotoh; Y Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  The mutation T315A in Candida albicans sterol 14alpha-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity.

Authors:  D C Lamb; D E Kelly; W H Schunck; A Z Shyadehi; M Akhtar; D J Lowe; B C Baldwin; S L Kelly
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

Review 5.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

6.  Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.

Authors:  Patrick Marichal; Luc Koymans; Staf Willemsens; Danny Bellens; Peter Verhasselt; Walter Luyten; Marcel Borgers; Frans C S Ramaekers; Frank C Odds; Hugo Vanden Bossche
Journal:  Microbiology       Date:  1999-10       Impact factor: 2.777

7.  The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans.

Authors:  T C White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

8.  Resistance mechanisms in clinical isolates of Candida albicans.

Authors:  Theodore C White; Scott Holleman; Francis Dy; Laurence F Mirels; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

9.  Drug resistance genes and trailing growth in Candida albicans isolates.

Authors:  Mi-Kyung Lee; Laura E Williams; David W Warnock; Beth A Arthington-Skaggs
Journal:  J Antimicrob Chemother       Date:  2003-12-19       Impact factor: 5.790

10.  Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.

Authors:  Yonghao Xu; Lamei Chen; Chunyang Li
Journal:  J Antimicrob Chemother       Date:  2008-01-24       Impact factor: 5.790

View more
  3 in total

Review 1.  Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.

Authors:  Andrew T Nishimoto; Cheshta Sharma; P David Rogers
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

2.  Principles of a New Protocol for Prediction of Azole Resistance in Candida albicans Infections on the Basis of ERG11 Polymorphisms.

Authors:  Monika Caban; Dominik Strapagiel; Jarosław Dziadek; Małgorzata Korycka-Machała; Agnieszka Grzelak
Journal:  Curr Microbiol       Date:  2016-04-23       Impact factor: 2.188

3.  Rapid detection of ERG11 polymorphism associated azole resistance in Candida tropicalis.

Authors:  Saikat Paul; Rajneesh Dadwal; Shreya Singh; Dipika Shaw; Arunaloke Chakrabarti; Shivaprakash M Rudramurthy; Anup K Ghosh
Journal:  PLoS One       Date:  2021-01-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.